Product Program year 2025 Source: CMS Open Payments

Ctexli

Drug Rare Disease

NDC 79378-310-90

Open in the dashboard

General payments

$249,233

110 payments

Research payments

$0

0 payments

Through program year 2025, $249,233 in general payments and $0 in research payments were reported against Ctexli (Rare Disease).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2025 General $249,233 110

Breakdown

Who paid General payments · program year 2025
  1. Mirum Pharmaceuticals, Inc. $249,233 110 payments
Top recipients General payments · program year 2025
  1. Ohsu Hospital And Clinics Teaching hospital · OR $87,345 35% · 27 payments
  2. Yasushi Kisanuki Neurology · Gahanna, OH $47,747 19% · 11 payments
  3. Paul Hillman Clinical Genetics (M.D.) · Houston, TX $36,712 15% · 6 payments
  4. Joseph Ray Clinical Genetics (M.D.) · Galveston, TX $24,478 10% · 6 payments
  5. Vikram Prakash Neurology with Special Qualifications in Child Neurology · Orlando, FL $14,070 6% · 7 payments

The top 5 of 47 recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Clinical Genetics (M.D.) Medical Genetics $73,366 45% · 4 practitioners
  2. Neurology Psychiatry & Neurology $53,296 33% · 4 practitioners
  3. Neurology with Special Qualifications in Child Neurology Psychiatry & Neurology $14,070 9% · 1 practitioner
  4. Endocrinology, Diabetes & Metabolism Internal Medicine $5,728 4% · 4 practitioners
  5. Ophthalmology $3,324 2% · 7 practitioners

The top 5 of 17 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Oregon $87,345 35% · 1 recipient
  2. Texas $62,985 25% · 11 recipients
  3. Ohio $50,901 20% · 2 recipients
  4. Florida $16,595 7% · 3 recipients
  5. Wisconsin $10,551 4% · 1 recipient

The top 5 of 17 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

110 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record